Hepatitis E virus chimeric DNA vaccine elicits immunologic response in mice

World J Gastroenterol. 2005 Nov 14;11(42):6713-5. doi: 10.3748/wjg.v11.i42.6713.

Abstract

Aim: To construct the plasmid pcHEV23 containing fragments of HEV ORF2 and ORF3 chimeric gene and to assess its ability to elicit specific immunologic response in mice.

Methods: The gene encoding the structural protein of HEV ORF2 fragment and full-length ORF3 was amplified by PCR. The PCR products were cloned into an eucaryotic expression plasmid pcDNA3. The resulting plasmid pcHEV23 was used as a DNA vaccine to inoculate BALB/c mice intramuscularly thrice at a dose of 100 or 200 microg. Mice injected with empty pcDNA3 DNA or saline served as control and then specific immune responses in the mice were detected.

Results: After 2-3 times of inoculation, all mice injected with pcHEV23 had anti-HEV IgG seroconversion and specific T lymphocyte proliferation. The lymphocyte stimulation index in the group immunized with pcHEV23 (3.1+/-0.49) was higher than that in the control group (0.787+/-0.12, P<0.01). None in the control group had a detectable level of anti-HEV IgG.

Conclusion: DNA vaccine containing HEV ORF2 and ORF3 chimeric gene can successfully induce specific humoral and cellular immune response in mice.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Female
  • Hepatitis E virus* / genetics
  • Hepatitis E virus* / immunology
  • Humans
  • Lymphocyte Activation
  • Mice
  • Mice, Inbred BALB C
  • Open Reading Frames
  • Plasmids / genetics
  • Plasmids / metabolism
  • Recombinant Fusion Proteins / genetics*
  • Recombinant Fusion Proteins / metabolism
  • T-Lymphocytes / immunology
  • Vaccines, DNA / immunology*
  • Viral Hepatitis Vaccines / immunology*

Substances

  • Recombinant Fusion Proteins
  • Vaccines, DNA
  • Viral Hepatitis Vaccines